Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
January 11, 2003
Follow-up after negative large loop excision of the transformation zone (LLETZ) of the cervix
M Moselhi, R E J Howells, A Hauke, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
Therapeutic vaccines for cervical cancer: concept and clinical results
A Fiander, S Man, L K Borysiewicz, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2002
Clinical studies of human papilloma vaccines in cervical cancer
M Adams, L Borysiewicz, A Fiander, et al.
Vaccine
|
January 18, 2003
Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R)
M Adams, H Navabi, B Jasani, et al.
Vaccine
|
March 21, 2001
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer
M Adams, L Borysiewicz, A Fiander, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 3, 2006
Survival in ovarian cancer in Wales: Prior to introduction of all Wales guidelines
T S Shylasree, R E J Howells, K Lim, et al.
British Journal of Cancer
|
November 15, 2011
Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial
A Castañon, A Tristram, D Mesher, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
January 17, 2018
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)
C N Hurt, Sef Jones, T-A Madden, et al.
Lancet (London, England)
|
June 1, 1996
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer
L K Borysiewicz, A Fiander, M Nimako, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
January 11, 2003
Follow-up after negative large loop excision of the transformation zone (LLETZ) of the cervix
M Moselhi, R E J Howells, A Hauke, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
Therapeutic vaccines for cervical cancer: concept and clinical results
A Fiander, S Man, L K Borysiewicz, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2002
Clinical studies of human papilloma vaccines in cervical cancer
M Adams, L Borysiewicz, A Fiander, et al.
Vaccine
|
January 18, 2003
Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R)
M Adams, H Navabi, B Jasani, et al.
Vaccine
|
March 21, 2001
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer
M Adams, L Borysiewicz, A Fiander, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 3, 2006
Survival in ovarian cancer in Wales: Prior to introduction of all Wales guidelines
T S Shylasree, R E J Howells, K Lim, et al.
British Journal of Cancer
|
November 15, 2011
Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial
A Castañon, A Tristram, D Mesher, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
January 17, 2018
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)
C N Hurt, Sef Jones, T-A Madden, et al.
Lancet (London, England)
|
June 1, 1996
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer
L K Borysiewicz, A Fiander, M Nimako, et al.
Page
of 3